Advertisement
Canada markets open in 5 hours 56 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7308
    +0.0011 (+0.15%)
     

  • CRUDE OIL

    82.98
    +0.17 (+0.21%)
     

  • Bitcoin CAD

    87,928.95
    -3,435.16 (-3.76%)
     

  • CMC Crypto 200

    1,391.53
    +8.95 (+0.65%)
     

  • GOLD FUTURES

    2,334.70
    -3.70 (-0.16%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,442.50
    -222.00 (-1.26%)
     

  • VOLATILITY

    16.26
    +0.29 (+1.82%)
     

  • FTSE

    8,084.38
    +44.00 (+0.55%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6815
    -0.0004 (-0.06%)
     

Did Aurora Cannabis Give Investors Reasons for Hope With Its Fiscal Q4 Results?

Sushree Mohanty, The Motley Fool
·4 min read
Did Aurora Cannabis Give Investors Reasons for Hope With Its Fiscal Q4 Results?

Depsite its dreadful performance over the last two years, investors may still hold out a smudge of hope that things will turn around for Canada-based marijuana producer Aurora Cannabis (NASDAQ: ACB). After all, a cursory glance at its historical stock prices indicates that Aurora did make some investors wealthy in the past. Since it started selling medical cannabis in the first quarter of 2016, Aurora's share price rose by as much as 2,400% through early 2018.

Continue reading